Athanasios Marneris, DO
Ophthalmology · Olympia Fields, ILNPI 1467866228
Payments from drug & device makers
Across 123 payments — averaging $153.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$16K
- Alcon$1K
- AbbVie$262
- Mallinckrodt Hospital Products Inc.$181
- Aerie Pharmaceuticals, Inc.$161
- Rxsight Inc$139
- plus $905 from 14 others
What the payments were for
- Consulting fees$15,00079%
- Speaking & faculty fees$2631%
- Food & beverage$3,61619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 22 | $15,906 |
| Alcon | 30 | $1,324 |
| AbbVie(2 entities) | 14 | $262 |
| Mallinckrodt Hospital Products Inc. | 11 | $181 |
| Aerie Pharmaceuticals, Inc. | 3 | $161 |
| Rxsight Inc | 3 | $139 |
| Rayner Intraocular Lenses Limited | 4 | $131 |
| Tarsus Pharmaceuticals, Inc. | 4 | $114 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $114 |
| Bausch & Lomb Americas Inc. | 6 | $111 |
| Sight Sciences, Inc. | 5 | $82 |
| Eyevance Pharmaceuticals LLC | 5 | $68 |
| Thea Pharma Inc. | 3 | $63 |
| Tearlab Corp | 1 | $60 |
| Glaukos Corporation | 1 | $38 |
| Dompe US, Inc. | 2 | $37 |
| Ivantis, Inc | 1 | $28 |
| Harrow Eye, LLC | 1 | $25 |
| LKC Technologies, Inc. | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Simplicity$15,263
- Tecnis IOL$15,259
- VERITAS Vision System$263
- ARGOS$243
- Centurion$197
- NGENUITY$148
- Rhopressa$124
- Rocklatan$124
- RXSIGHT INJECTOR HANDPIECE$100
- RXSIGHT CONTACT LENS$100
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$100
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$100
- RXSIGHT INJECTOR CARTRIDGE$100
How this compares
$18,878 in reported general payments places this provider in the 85th percentile of 773 ophthalmology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 41 | $25,002 |
| RhopressaNetarsudil Mesylate | 11 | $9,937 |
| Latanoprost | 562 | $7,764 |
| CombiganBrimonidine Tartrate/Timolol | 12 | $5,801 |
| BesivanceBesifloxacin Hcl | 20 | $4,516 |
| Lotemax SmLoteprednol Etabonate | 17 | $4,337 |
| ProlensaBromfenac Sodium | 11 | $3,965 |
| Prednisolone Acetate | 68 | $3,341 |
| ValacyclovirValacyclovir Hcl | 28 | $2,160 |
| Brimonidine Tartrate | 189 | $1,854 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 114 | $1,807 |
| Dorzolamide Hcl | 35 | $1,011 |
| ErythromycinErythromycin Base | 78 | $815 |
| Timolol Maleate | 68 | $705 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 31 | $226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan | $262 | $30,80453 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCBesivance, Lotemax Sm, Prolensa | $114 | $12,81848 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa | $161 | $9,93711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 773 ophthalmology providers in Illinois.
Other ophthalmology in Olympia Fields
- Samuel MultackOlympia Fields$272K
- Veeral ShethOak Forest$14.8M
- Seenu HariprasadChicago$2.3M
- Lisa NijmSpringfield$1.9M
- Manjot GillChicago$1.4M
- Mitchell JacksonLake Villa$1.4M
- Ramanath BhandariSpringfield$1.2M
- Kathleen MornoNorth Riverside$1.2M
- Amani FawziChicago$864K
- Navaneet Chailert BorisuthRock Island$737K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.